Intriguingly, we observed that EZH2 was strongly overexpressed in high-grade DCIS adjacent to triple-negative breast carcinoma, whereas UDH in benign lesions did not overexpress EZH2. Here, EZH2 is linked to ductal breast carcinoma in situ.